Hutch News

Hutch News

Stories tagged 'Herpes Simplex Virus-2'

Stealing a secret from an unwelcome virus

An unexpected discovery in a herpes lab might bring relief to cancer patients

June 29, 2017 | By Sabin Russell / Fred Hutch News Service

Drs. Jia Zhu and Tao Peng made a unexpected discovery while searching for a treatment for herpes: The virus prompts skin cells to make a protein that keeps sensory nerves healthy, and might lead to a treatment for peripheral neuropathy, a side effect of chemotherapy.

View story >


Experimental herpes drug more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows

Dec. 20, 2016 | By Mary Engel / Fred Hutch News Service

The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.

View story >


Halting herpes' transmission

New Hutch study predicts threshold of viral load for passing herpes from one person to another

March 25, 2014 | By Mary Engel

Fred Hutch researchers used mathematical models to predict viral loads below which transmission of the herpes virus is unlikely to occur. Preventing transmission is critical because there is no cure for herpes.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.